Clinical Trial: A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866977) titled 'A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer' on March 04.

Brief Summary: This is a single-center, single-arm, open label investigator-initiated clinical study to evaluate the efficacy and safety of VRT106 in combination with chemotherapy in the treatment of advanced pancreatic cancer.

Study Start Date: March 12

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: DRUG: Oncolytic virus VRT106

VRT106, IV

DRUG: Chemotherapy

21 days/cycle

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Xiangya Hospital o...